Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3β and phosphorylated AKT expression levels

Jia-Rong Jheng,Chung-Fan Hsieh,Yu-Hsiu Chang,Jin-Yuan Ho,Wen-Fang Tang,Zi-Yi Chen,Chien-Jou Liu,Ta-Jen Lin,Li-Yu Huang,Jyh-Haur Chern,Jim-Tong Horng
DOI: https://doi.org/10.1016/j.jmii.2022.04.012
2022-08-01
Abstract:BackgroundThe purpose of this study was to examine the in vivo activity of rosmarinic acid (RA) – a phytochemical with antioxidant, anti-inflammatory, and antiviral properties – against influenza virus (IAV). An antibody-based kinase array and different in vitro functional assays were also applied to identify the mechanistic underpinnings by which RA may exert its anti-IAV activity.MethodsWe initially examined the potential efficacy of RA using an in vivo mouse model. A time-of-addition assay and an antibody-based kinase array were subsequently applied to investigate mechanism-of-action targets for RA. The hemagglutination inhibition assay, neuraminidase inhibition assay, and cellular entry assay were also performed.ResultsRA increased survival and prevented body weight loss in IAV-infected mice. In vitro experiments revealed that RA inhibited different IAV viruses – including oseltamivir-resistant strains. From a mechanistic point of view, RA downregulated the GSK3β and Akt signaling pathways – which are known to facilitate IAV entry and replication into host cells.ConclusionsRA has promising preclinical efficacy against IAV, primarily by interfering with the GSK3β and Akt signaling pathways.
immunology,infectious diseases,microbiology
What problem does this paper attempt to address?